Fosun Pharma Received NMPA Approval for Wan Ti Le (Tenapanor Hydrochloride Tablets) ...Middle East

News by : (PR Newswire) -

Bringing New Hope to Chinese Dialysis Patients with Hyperphosphatemia SHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma; stock code: 600196.SH, 02196.HK) announced that its holding subsidiary, Shanghai Fosun Pharmaceutical Industrial...

Read More Details
Finally We wish PressBee provided you with enough information of ( Fosun Pharma Received NMPA Approval for Wan Ti Le (Tenapanor Hydrochloride Tablets) )

Also on site :

Most Viewed News
جديد الاخبار